News & Comment

What types of life science enterprises are attracting venture capitalists today?

Stan Crooke details the challenges in building a venture around an innovative platform and the implications for the industry going forward.

Building any biotech business is hard, but building one based on a new, unproven technology or approach requires special care.

Non-dilutive funding from government programs can help startups move forward.

With careful due diligence, help from financiers and a keen eye, even small companies can grow through mergers and acquisitions.

How should you go about protecting the assets in your business?

Startup or not, your company needs to put in place a process for establishing and maintaining high-quality financial records.

A gathering of biotech leaders in Sweden attempts to share candid opinions on the most successful strategies for building a biotech in Europe.

In the current fund-raising environment, focusing on rapid decision making, spreading risk across several assets and introducing innovative trial designs could pay dividends for biotech entrepreneurs.

As more startups share competitive business information in their search for partners within big pharma or biotech, what legal protections are available if their intellectual property is infringed upon?

A blocking patent can kill your business before it's off the ground.

Job security in big pharma is not what it once was. For those looking for a new challenge, a group of big company refugees recount their experience starting up a new life science venture.

What's involved in formally starting a biotech company?

Toiling away at the university, you've just made your once-in-a-lifetime discovery. Here's how to survive what comes next.

The hardest—and perhaps loneliest—period of being an entrepreneur might be just after your company is founded.

When seeking a licensing partner for a product in development, market projections and strategies require substantiation. This can be provided through physician interviews.

You don't always have to go to venture capitalists to raise funds. Proper planning and research can help you bring in millions through other avenues.

In an industry with a lengthy product development timeline, capital efficiency is paramount. But successful capital-efficient strategies require a different approach to thinking, working and fundraising.

Preferred stock preferences bite into an entrepreneur's returns. What can you do to put venture capitalists on a diet?